142 related articles for article (PubMed ID: 30094784)
1. Current Level of Glycemic Control and Clinical Inertia in Subjects Using Insulin for the Treatment of Type 1 and Type 2 Diabetes in the Czech Republic and the Slovak Republic: Results of a Multinational, Multicenter, Observational Survey (DIAINFORM).
Brož J; Janíčková Žďárská D; Urbanová J; Brabec M; Doničová V; Štěpánová R; Martinka E; Kvapil M
Diabetes Ther; 2018 Oct; 9(5):1897-1906. PubMed ID: 30094784
[TBL] [Abstract][Full Text] [Related]
2. How well we treat with insulin in the Czech Republic and in the Slovak Republic A summary of results and comments on the original Czech-Slovak DIAINFORM study.
Brož J; Žďárská DJ; Urbanová J; Doničová V; Martinka E; Kvapil M
Vnitr Lek; 2019; 65(4):279-283. PubMed ID: 31091947
[TBL] [Abstract][Full Text] [Related]
3. Addition of Basal Insulin to Oral Antidiabetic Agents in Patients with Inadequately Controlled Type 2 Diabetes Leads to Improved HbA1c Levels: Metabolic Control, Frequency of Hypoglycemia, and Insulin Titration Analysis as Results of a Prospective Observational Study (BALI Study).
Brož J; Janíčková Ždárská D; Štěpánová R; Kvapil M
Diabetes Ther; 2019 Apr; 10(2):663-672. PubMed ID: 30788806
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of lixisenatide for treatment of diabetes in the real world: data from the Monitoring Registry in a Real-Life Cohort in the Czech and Slovak Republic.
Haluzík M; Adamíková A; Běhunčík M; Macko M; Štěpánová R
Vnitr Lek; 2018; 64(4):357-366. PubMed ID: 29791170
[TBL] [Abstract][Full Text] [Related]
5. Insulin Management of Patients with Inadequately Controlled Type 2 Diabetes Admitted to Hospital: Titration Patterns and Frequency of Hypoglycemia as Results of a Prospective Observational Study (Hospital Study).
Brož J; Janíčková Žďárská D; Urbanová J; Piťhová P; Doničová V; Pálová S; Pelechová B; Smržová A; Kvapil M
Diabetes Ther; 2021 Jul; 12(7):1799-1808. PubMed ID: 34028699
[TBL] [Abstract][Full Text] [Related]
6. [RESOLUTE Study in the Czech Republic: insulin glargine improves the compensation of type 2 diabetes in patients with unsatisfactory results of therapy with a combination of insulin detemir and oral antidiabetics. Results of the nonintervention RESOLUTE Project in the Czech Republic].
Kvapil M
Vnitr Lek; 2013 Sep; 59(9):800-6. PubMed ID: 24073952
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of vildagliptin as a second-line therapy vs other oral antidiabetic agents in patients with type 2 diabetes: Czech results within the worldwide prospective cohort EDGE study].
Haluzík M; Veselá V; Gerle J; Brada M; Dohnalová L; Edelsberger T; Houdová J
Vnitr Lek; 2013 Dec; 59(12):1049-56. PubMed ID: 24350936
[TBL] [Abstract][Full Text] [Related]
8. BrazIliaN Type 1 & 2 DiabetEs Disease Registry (BINDER): longitudinal, real-world study of diabetes mellitus control in Brazil.
de Almeida-Pititto B; Eliaschewitz FG; de Paula MA; Ferreira GC
Front Clin Diabetes Healthc; 2022; 3():934629. PubMed ID: 36992732
[TBL] [Abstract][Full Text] [Related]
9. Gaps Remain for Achieving HbA1c Targets for People with Type 1 or Type 2 Diabetes Using Insulin: Results from NHANES 2009-2020.
Hankosky ER; Schapiro D; Gunn KB; Lubelczyk EB; Mitroi J; Nelson DR
Diabetes Ther; 2023 Jun; 14(6):967-975. PubMed ID: 37067668
[TBL] [Abstract][Full Text] [Related]
10. The Trend of High-Dose Insulin Usage Among Patients with Diabetes in the UK: A Retrospective Study.
Idris I; Peng X; He X; Liu D; Balogh E; Kaushik P; Van Brunt K
Diabetes Ther; 2018 Dec; 9(6):2245-2257. PubMed ID: 30269224
[TBL] [Abstract][Full Text] [Related]
11. Improved Glycemic Control in a Patient Group Performing 7-Point Profile Self-Monitoring of Blood Glucose and Intensive Data Documentation: An Open-Label, Multicenter, Observational Study.
Sieber J; Flacke F; Link M; Haug C; Freckmann G
Diabetes Ther; 2017 Oct; 8(5):1079-1085. PubMed ID: 28913822
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis-related diabetes compared with type 1 and type 2 diabetes in adults.
Konrad K; Scheuing N; Badenhoop K; Borkenstein MH; Gohlke B; Schöfl C; Seufert J; Thon A; Holl RW
Diabetes Metab Res Rev; 2013 Oct; 29(7):568-75. PubMed ID: 23704008
[TBL] [Abstract][Full Text] [Related]
13. [Basal insulin glargine using a basal-bolus regimen in a common clinical practice: observational, non-interventional, multicenter, national project LINDA (Lantus in daily practice - safety and efficacy in basal bolus regimen)].
Zďarská DJ; Brož J; Křivská B; Rušavý Z; Kvapil M
Vnitr Lek; 2014 Sep; 60(9):712-9. PubMed ID: 25294758
[TBL] [Abstract][Full Text] [Related]
14. Long-term safety and effectiveness of biosimilar insulin glargine in Japanese patients with diabetes mellitus in routine clinical practice: results of a post-marketing safety study.
Shingaki T; Taki K; Koyanagi M; Nagaoka S; Yoshizawa K; Oki N; Yoshikawa A; Imaoka T
Curr Med Res Opin; 2020 Jun; 36(6):947-958. PubMed ID: 32271092
[No Abstract] [Full Text] [Related]
15. Characteristics of Patients with Type-1 or Type-2 Diabetes Receiving Insulin Glargine U300: An Analysis of 7268 Patients Based on the DPV and DIVE Registries.
van Mark G; Lanzinger S; Sziegoleit S; Putz FJ; Durmaz M; Borscheller M; Danne T; Seufert J; Holl RW; Bramlage P
Adv Ther; 2019 Jul; 36(7):1628-1641. PubMed ID: 31119688
[TBL] [Abstract][Full Text] [Related]
16. Results of Insulin Therapy in Type 2 Diabetes Mellitus Patients in the Czech Republic: Do They Reflect the Current Status in Other Countries?
Brož J; Janíčková Ždárská D; Urbanová J
Diabetes Ther; 2019 Aug; 10(4):1181-1188. PubMed ID: 31131435
[TBL] [Abstract][Full Text] [Related]
17. A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin.
Shepherd MH; Shields BM; Hudson M; Pearson ER; Hyde C; Ellard S; Hattersley AT; Patel KA;
Diabetologia; 2018 Dec; 61(12):2520-2527. PubMed ID: 30229274
[TBL] [Abstract][Full Text] [Related]
18. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.
Mata-Cases M; Benito-Badorrey B; Roura-Olmeda P; Franch-Nadal J; Pepió-Vilaubí JM; Saez M; Coll-de-Tuero G;
Curr Med Res Opin; 2013 Nov; 29(11):1495-502. PubMed ID: 23944631
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States.
Ali SN; Dang-Tan T; Valentine WJ; Hansen BB
Adv Ther; 2020 Feb; 37(2):869-882. PubMed ID: 31925649
[TBL] [Abstract][Full Text] [Related]
20. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
